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The endolysosomal system is critical for the mainte-
nance of cellular homeostasis. However, how endoly-
sosomal compartment is regulated by mitochondrial
function is largely unknown. We have generated a
mouse model with defective mitochondrial function
in CD4+ T lymphocytes by genetic deletion of the
mitochondrial transcription factor A (Tfam). Mito-
chondrial respiration deficiency impairs lysosome
function, promotes p62 and sphingomyelin accumu-
lation, and disrupts endolysosomal trafficking path-
waysandautophagy, thus linkingaprimarymitochon-
drial dysfunction to a lysosomal storage disorder. The
impaired lysosome function in Tfam-deficient cells
subvertsTcell differentiation towardproinflammatory
subsets and exacerbates the in vivo inflammatory
response. Restoration of NAD+ levels improves lyso-
some function and corrects the inflammatory defects
in Tfam-deficient T cells. Our results uncover amech-
anism by which mitochondria regulate lysosome
function to preserve T cell differentiation and effector
functions, and identify strategies for intervention in
mitochondrial-related diseases.
INTRODUCTION
Mitochondria are multifunctional organelles that integrate cell
metabolism by regulating important anabolic and catabolic path-
ways. Mitochondria integrate their diverse functions through
multiple pathways that ultimately converge on proper function
of the respiratory complexes of the electron transport chain
(Friedman and Nunnari, 2014). The subunits of these mitochon-
drial complexes are encoded by both nuclear and mitochondrial
DNA (mtDNA), and a correct balance among them is critical
to maintaining the function of the electron transport chain, andCell Meis associated with organismal lifespan (Gomes et al., 2013;
Houtkooper et al., 2013). The mitochondrial transcription factor
A (Tfam) is the most abundant mtDNA-associated protein in
mammalian cells, and its expression controls mtDNA copy num-
ber in cells, making it an essential player in the maintenance,
transcription, and replication of mtDNA (Ekstrand et al., 2004;
Larsson et al., 1998). Global deletion of Tfam is embryonically le-
thal, but tissue-specific ablation of this factor disrupts respira-
tory chain function in selected cell populations and generates a
variety of alterations that recapitulate important phenotypes of
human mitochondrial diseases (Vernochet et al., 2012; Viader
et al., 2013).
Mitochondria are dynamic organelles that modify their distri-
bution, structure, and function in response to changing circum-
stances such as oxygen availability or stress (Acı´n-Pe´rez et al.,
2014; Detmer and Chan, 2007; Lapuente-Brun et al., 2013).
Moreover, the crosstalk of mitochondria with other intracellular
organelles is crucial during cell adaptation to stresses and for
the preservation of organelle functionality (Rowland and Voeltz,
2012). Contacts between mitochondria and the endoplasmic
reticulum form critical hubs implicated in the regulation of
mitochondrial fission, calcium homeostasis, ATP production,
apoptosis, and lipid metabolism, and deregulation of these con-
tacts can lead to disease (Arruda et al., 2014). In addition, mito-
chondrial contacts with the lysosome-related vacuole in yeast
(Elbaz-Alon et al., 2014; Ho¨nscher et al., 2014) and with melano-
somes in melanocytes (Daniele et al., 2014) have been shown to
modulate lipid homeostasis and organelle function. Defining the
intricate communication of mitochondria with other intracellular
organelles is thus critical for understanding essential physiolog-
ical processes and how their dysfunction might contribute to the
development of human disease.
The endolysosomal system is a dynamic membrane compart-
ment critical to the maintenance of cellular homeostasis. Endo-
somes, multivesicular bodies, and lysosomes regulate signaling,
secretion, and the recycling and degradation of protein and
lipid cellular components. Lysosomes are critical organelles
with degradative and recycling functions, but also mediate
other fundamental processes such as plasma membrane repair,tabolism 22, 485–498, September 1, 2015 ª2015 Elsevier Inc. 485
signaling, and regulation of lipid metabolism (Settembre et al.,
2013b). Lysosome biogenesis and function are subjected to
transcriptional regulation by the transcription factor EB (TFEB),
which allows adaptation of lysosomal function to different phys-
iological conditions (Medina et al., 2015). Alterations to lysosome
function and endolysosomal trafficking pathways are mostly
found in lysosomal storage disorders (LSDs). LSDs are caused
either by deficiency of lysosomal proteins or by changes in
non-lysosomal proteins that result in the accumulation of unde-
graded substrates in lysosomes and abnormal storage of
lipids such as sphingomyelins (SMs), triacylglycerides (TAGs),
glycosphingolipids, or sphingosines (Futerman and van Meer,
2004). Remarkably, lysosomal dysfunction in Gaucher disease
blocks mitochondrial turnover by mitophagy (Osellame et al.,
2013), thus connecting the lysosome degradation capacity to
the maintenance of a healthy mitochondrial repertoire. Whether
mitochondria regulate the biogenesis and function of the endoly-
sosomal compartment is still unknown.
During adaptive immune responses, naive CD4+ T cells that
encounter a foreign antigen must reprogram their metabolism
to meet the costly biosynthetic and bioenergetic demands of
cellular activation, proliferation, and effector function (Pearce
et al., 2013). T cells reorient their metabolism toward aerobic
glycolysis. Although less efficient at ATP synthesis, glycolysis
generates intermediate metabolites that support biosynthetic
pathways for effector functions, including cytokine production
(Chang et al., 2013). Because of the glycolytic nature of T
lymphocyte metabolism, the role of mitochondria in T cell func-
tion has been traditionally neglected. However, accumulating
evidence indicates that T cell effector functions require mito-
chondrial oxygen consumption, ATP, and ROS (Weinberg
et al., 2015).
To investigate the mechanisms by which mitochondria influ-
ence T cell responses and ultimately affect immune disease pro-
gression, we have generated a mouse model in which mito-
chondrial function is specifically disrupted in the adaptive
immune system by targeting Tfam in CD4+ T cells. Tfam-defi-
cient cells have below-normal levels of mtDNA, diminished mito-
chondrial respiration, and a metabolic signature characterized
by increased anaerobic glycolysis and impaired fatty acid
b-oxidation. Respiration-impaired cells show reduced lysosomal
calcium mobilization and impaired lysosomal degradation ca-
pacity revealed by p62 and SM accumulation, defects that cells
try to compensate by inducing lysosome biogenesis through the
TFEB. The impaired lysosome function in Tfam-deficient cells
subverts T cell differentiation toward proinflammatory subsets
and exacerbates the in vivo inflammatory response. Improve-
ment of lysosome function by restoration of NAD+/NADH bal-
ance through NAD+ precursors corrected inflammatory defects
in Tfam-deficient T cells. These data reveal a mechanism by
which mitochondria regulate lysosome function to preserve
T cell differentiation and effector functions.
RESULTS
Tfam Depletion Impairs Respiratory-Chain Function in
T Cells
To investigate the involvement of mitochondria in the regulation
of endolysosomal function and T cell responses, we generated a486 Cell Metabolism 22, 485–498, September 1, 2015 ª2015 Elseviemouse model of mitochondrial dysfunction by specifically delet-
ing Tfam in CD4+ T cells. This was achieved by crossing mice
with loxP-flanked Tfam alleles (Tfamfl/fl) with CD4-Cre mice.
Consistent with gene deletion in the early stages of T cell devel-
opment, Tfam deletion efficiently decreased the mRNA of Tfam
in CD4+ and in CD8+ T naive lymphocytes (see Figures S1A
and S1B). CD4Cre+/wtTfamfl/fl mice (herein Tfam/ mice) devel-
oped normally and showed similar frequency of CD4 and CD8
single-positive and double-positive thymocytes to their control
littermates (Figure 1A), indicating that Tfam is not required during
early T cell development. Tfam/ mice presented slightly lower
percentages of CD4+ and CD8+ T cells in the spleen and periph-
eral lymph nodes (Figure 1B), but had similar numbers of spleno-
cytes, B cells and dendritic cells to littermate CD4Crewt/wtTfamfl/fl
controls (herein WT mice) (Figure S1C).
Naive Tfam/ CD4+ T cells expressed comparable levels of
T cell surface markers to WT cells and responded normally
to in vitro differentiation toward T lymphoblasts, adopting a
polarized morphology (Figures 1C and 1D). The levels of Tfam
were suppressed throughout lymphoblast differentiation, ex-
cluding the selection of Tfam-positive cells during in vitro
expansion (Figures 1E and 1F). Consistent with the close rela-
tionship between levels of Tfam and mtDNA, lack of Tfam
induced a severe decrease in mtDNA content, both in Tfam/
CD4+ T lymphoblasts and in human Jurkat T cells stably trans-
fected with Tfam short hairpin RNAs (shTfam) (Figures 1G
and S1D). Tfam deficiency reduced the mRNA expression
of mtDNA-encoded subunits of mitochondrial complexes I, III,
IV, and V, whereas nuclear-encoded subunits were not affected
(Figure 1H). Consistently, the protein levels of complexes I and
IV, which include mtDNA-encoded subunits, were below
normal, whereas the nuclear-encoded complex II was unaf-
fected (Figure 1I).
In response to these respiratory-chain alterations, Tfam-defi-
cient cells increased mitochondrial mass (Figure 2A). However,
electron microscopy analysis revealed severely aberrant mito-
chondrial morphology in Tfam/ CD4+ T cells, impaired cristae
organization, and loss of mitochondrial electron density (Fig-
ure 2B), consistent with a mitochondrial dysfunction caused by
Tfam depletion.
Blue native gel electrophoresis (BNGE) of extracts from Tfam-
silenced cells revealed severe loss of complexes I and III, but not
II, and associated alterations in mitochondrial supercomplex as-
sembly (Figure 2C). Accordingly, Tfam-depleted cells showed
stronger impairment of electron transport from NADH (com-
plexes I+III) than from FADH2 (complexes II+III) (Figure 2D),
demonstrating an imbalance in the NAD+/NADH ratio in respira-
tory-chain impaired cells. Connected with the reduced electron
transport chain function, Tfam-deficient T cells also had below-
normal content of mitochondrial reactive oxygen species (ROS)
(Figure 2E), reduced mitochondrial ATP generation (Figure 2F),
and impaired survival in galactose medium (Figure S1E). Inhibi-
tion of electron transport chain function by oligomycin treatment
caused a transient hyperpolarization in WT cells, where mito-
chondrial membrane potential is maintained by OXPHOS func-
tion. In contrast, oligomycin treatment did not increase mito-
chondrial membrane potential in Tfam/ cells, in agreement
with absence of mtDNA-encoded F0 subunits (Appleby et al.,
1999; Buchet and Godinot, 1998) (Figure S1F). The maintenancer Inc.
Figure 1. Tfam Depletion Induces Severe mtDNA Deficiency in T Cells
(A) Dot plots show CD4 and CD8 expression in thymocytes from WT and Tfam/ mice. Right, percentage of CD4 and CD8 single-positive (SP), and CD4/CD8
double-positive (DP) cells.
(B) Dot plots show CD4 and CD8 T cells, and CD3 and B220 cells from the spleens. Right, percentages of CD4 and CD8 cells in the spleen, inguinal (ILN), and
mesenteric lymph nodes (MLN) (n = 11).
(C) Expression of cell-surface markers in naive CD4 T cells and T-lymphoblasts differentiated with ConA (48 hr) and IL-2 (4 days).
(D) Confocal images show polarization of cytoskeletal components in T lymphoblasts by actin, tubulin, and ERM (ezrin-radixin-moesin) staining. Scale bar, 10 mm.
(E) Relative Tfam mRNA levels by RT-PCR in naive CD4 T cells (day 0) and during lymphoblast differentiation.
(F) Tfam mRNA (left) and protein levels (right) in CD4 T lymphoblasts.
(G) mtDNA levels (mtCO1 and mtND1) relative to nuclear DNA (SDH) in CD4 T lymphoblasts.
(H) mRNA levels of mtDNA-encoded and genome-encoded mitochondrial subunits.
(I) Immunoblot of T lymphoblastmitochondrial proteins. Complex I (CI) was detectedwith anti-NDUFA9, CII with anti-FpSDH, andCIVwith anti-COX1. Tom20was
used as loading control. Data (B and E–H) are means ± SEM (n > 3); *p < 0.05, **p < 0.01, and ***p < 0.001 (Student’s t test).of mitochondrial membrane potential in mtDNA-depleted cells is
thought to require the reverse function of the F1-ATPase and ac-
tion of the adenine nucleotide carrier (Appleby et al., 1999; Bu-
chet and Godinot, 1998). Despite the effect on electron transport
chain function and mitochondrial ATP production, total cellular
ATP content in primary CD4+ Tfam/ T cells and Jurkat shTfam
T cells was comparable with controls (Figures 2G and S1G). In
addition, the phosphorylation level of the metabolic sensorCell MeAMP-activated protein kinase (AMPK) did not differ between
Tfam-deficient and control cells (Figure 2H), indicating that
global energy status is not compromised in Tfam-depleted cells.
We then analyzed the metabolic consequences of Tfam dele-
tion on CD4+ T cells by flux analysis. In activated CD4+ T cells,
wemeasured the extracellular acidification rate (ECAR), as an in-
dex of lactate production and glycolysis, and the oxygen con-
sumption rate (OCR) as an indicator of mitochondrial oxidativetabolism 22, 485–498, September 1, 2015 ª2015 Elsevier Inc. 487
Figure 2. Tfam Ablation Induces OXPHOS Deficiency in T Cells
(A) Left, flow cytometry analysis of Mitotracker staining. Right, confocal images of mitochondria (anti-MnSOD), and nuclei HOECHST58 (H58, blue) in T lym-
phoblasts. Scale bar, 10 mm.
(B) Electron microscopy images in T lymphoblasts.
(C) Blue native gel electrophoresis analysis of electron-transport-chain complexes (NDUFA9, FpSDH, and Core1 for complexes I, II, and III, respectively) from
three WT and Tfam/ T cell lysates.
(D) Combined mitochondrial complex activities in Jurkat T cells. Lines extending from the boxes indicate the variability outside the upper and lower quartiles.
(E) Flow cytometry analysis of mROS in T lymphoblasts stained with MitoSOX.
(F) Glutamate- and pyruvate-driven ATP-dependent production in Jurkat T cells.
(G) Cellular ATP content in WT and Tfam/ T cells.
(H) Immunoblot analysis of AMPK phosphorylation at Thr172 in T lymphoblasts. Actin was used as a loading control.
(I) CD3/CD28-activated CD4 T cells fed either with glucose or palmitate (FA) for 2 hr and oxygen consumption rate (OCR) and extracellular acidification rate
(ECAR) measured in real time (upper panels). Lower panels show the basal OCR and ECAR from a representative experiment. Data (A and D–G) aremeans ± SEM
(nR 3, *p < 0.05, Student’s t test).phosphorylation (OXPHOS). Upon activation with anti-CD3 and
anti-CD28, wild-type T cells used glycolysis and OXPHOS for
glucose consumption, as described (Michalek et al., 2011;
Pearce et al., 2013). In contrast, Tfam/ T cells presented a
low OCR and an ECAR above WT levels, demonstrating anaer-
obic glucose utilization (Figure 2I). Additionally, we examined
mitochondrial fatty acid b-oxidation (FAO) in respiration-defi-488 Cell Metabolism 22, 485–498, September 1, 2015 ª2015 Elseviecient cells. Naive CD4+ T cells were activated over 48 hr and
then incubated with fatty acids prior to flux analysis. In these
conditions, activated wild-type CD4+ T cells showed increased
OXPHOS and reduced glycolysis, thus relying on FAO and mito-
chondrial OXPHOS for energy production. In contrast, Tfam/
T cells showed reduced OCR, supporting the conclusion that
FAO is impaired in respiratory-chain deficient cells (Figure 2I).r Inc.
Figure 3. Tfam Regulates Lysosomal Biogenesis through TFEB
(A) Electron microscopy images show the abnormal intracellular accumulation of vesicles in Tfam/ T lymphoblasts. Scale bar, 2 mm.
(B) Flow cytometry analysis of EEA1, HRS, LBPA, LAMP1, and lysotracker content in CD4 T lymphoblasts. Results showmean fluorescence intensity (m.f.i., n = 3).
(C) Confocal images of HRS, LBPA, and LAMP1 in T lymphoblasts. Nuclei were stained with HOECHST58 (H58, blue). Scale bar, 10 mm.
(D) Confocal images of TFEB (green), LAMP1 (red), and H58 (blue) in Oli-Neu cells. Right, quantification of nuclear TFEB m.f.i.
(E) Cytosolic and nuclear fractions of Jurkat cells blotted for TFEB, tubulin, and histone 2A (H2A). Chart shows densitometry analysis of the ratio of nuclear TFEB to
H2A (n = 3).
(F) RelativemRNA levels of TFEB and target genes in T lymphoblasts by RT-PCR (n = 5). Data (B and D–F) aremeans ± SEM; *p < 0.05, **p < 0.01, and ***p < 0.001
(Student’s t test).Tfam deletion thus promotes loss of mtDNA, OXPHOS defi-
ciency, and compromised mitochondrial function, but has no
significant impact on cellular energy status or survival. Addition-
ally, impaired mitochondrial respiration induces a metabolic re-
programming characterized by increased anaerobic glucose
consumption and impaired FAO.
Respiration-Impaired Cells Increase Lysosomal
Compartment through TFEB
In addition to the profound morphological and functional mito-
chondrial alterations, electron microscopy studies revealed
striking intracellular vesiculation in Tfam-deficient cells (Fig-
ure 3A). These abnormalities prompted us to explore the role
of mitochondria in the abundance and organization of the endo-
lysosomal compartment. By flow cytometry, the early endosome
marker EEA1 showed no substantial differences, but expression
of the late endosomal markers HRS and lysobisphosphatidicCell Meacid (LBPA) was elevated in respiratory-chain impaired cells
(Figure 3B). Immunofluorescence analysis revealed enlargement
of late endosomes in Tfam/ cells (Figures 3C). In addition, lyso-
somes, identified by staining for LAMP1 and Lysotracker, ap-
peared to be more abundant in Tfam/ cells than in wild-types
(Figures 3B and 3C), indicating the expansion of the late endo-
some and lysosome compartment in cells that lack Tfam.
Lysosomal biogenesis is regulated by TFEB, a master regu-
lator of the coordinated lysosomal expression and regulation
(CLEAR) gene network (Sardiello et al., 2009). During lysosomal
stress or starvation, cytosolic TFEB relocates to the nucleus and
activates a transcriptional program aimed at increasing auto-
phagy and lysosomal biogenesis and function (Settembre
et al., 2013b). TFEB is also responsible for the transcriptional
activation of PGC1a, which adjusts the content of mitochondrial
and peroxisomal enzymes and the expression of components
that increase lipid catabolic reactions (Settembre et al., 2013a).tabolism 22, 485–498, September 1, 2015 ª2015 Elsevier Inc. 489
Confocal analysis revealed that TFEB translocates to the nucleus
in Tfam-depleted cells (Figures 3D and S2A). Nuclear localization
of TFEB was confirmed by cell fractionation assays (Figure 3E
and S2B) and correlated with upregulated expression of the
TFEB target genes LAMP1, ATP6V0, CtsB, FABP3, CD36,
Acacb, Cyp4a10, and PGC1a (Figure 3F), which are involved in
lipid uptake, lipid catabolism, and lysosomal and mitochondrial
function. These results suggest that the enlarged lysosomal
compartment observed in respiration-impaired Tfam/ cells is
associated with TFEB activation.
Mitochondrial Dysfunction Promotes Lysosomal
Disorder and Sphingolipidosis
To further examine the impact of Tfam deficiency on lysosome
function, we measured the levels of calcium in lysosomes after
inducing its release with bafilomycin-A1 (Lloyd-Evans et al.,
2008), a selective inhibitor of the vacuolar-type H+ ATPase.
Lysosomal calcium mobilization was weaker in Tfam-deficient
cells (Figure 4A), whereas the subsequent addition of ionomy-
cin, which releases calcium from remaining stores, triggered
comparable release in WT and Tfam/ T cells. Measurement
with a specific lysosomal pH-sensitive probe indicated reduced
pH in lysosomes from respiration-impaired Tfam/ cells (Fig-
ure S3A). The activity of the lysosomal endopeptidase cathepsin
B was significantly reduced in Tfam/ T cells (Figure 4B),
whereas acid phosphatase activity showed no difference
(Figure S3B).
SMs and other lipids such as cholesterol, glycosphingolipids
and sphingosine accumulate abnormally in LSDs (Futerman
and van Meer, 2004). Lipidomic analysis showed that CD4+
Tfam/ T cells have an altered lipid profile compared with
wild-types, affecting 90 out of 218 lipids analyzed and character-
ized by elevated levels of several lipid species (Figure 4D).
Consistent with the reduced lysosomal degradation capacity,
respiration-impaired Tfam/ cells showed a significant accu-
mulation of SMs and TAGs (Figures 4D and S3C). Supporting
lysosomal dysfunction and SM accumulation in respiration-
impaired cells, Tfam/ T cells showed significantly reduced
acid sphingomyelinase (ASM) activity (Figure 4C).
To dissect how mitochondria regulate lysosomal function, we
investigated whether cells containing point mutations in mtDNA
genes for specific mitochondrial respiratory complexes undergo
the same lysosomal calcium defects. Mouse fibroblasts that
carry a high load (98%) of a null mutation in the mt-ND6 gene
(complex I subunit, CI) showed impaired lysosomal calcium
mobilization, upregulation of TFEB target genes, and reduced
ASM activity (Figures 4E–4G). Notably, impaired lysosomal cal-
cium mobilization was also detected in fibroblasts from two hu-
man patients, one carrying a high load (88%) of a point mutation
in the mt-tRNAAsn gene (m.5658T>C), and another carrying a
50% load of a point mutation in the CI subunit mt-ND5 gene
(m.13513G>A) (Figure 4H). These results indicate that lysosomal
calcium levels are decreased not only by the severe OXPHOS
deficiency associated with Tfam depletion, but also by point mu-
tations in mtDNA associated with CI dysfunction, both in mice
and in human patient samples.
Defects in lipid trafficking and autophagosome-lysosome
fusion are commonly observed in sphingolipidoses. The reduced
lysosomal calcium and abnormal SM accumulation detected in490 Cell Metabolism 22, 485–498, September 1, 2015 ª2015 Elsevierespiration-impaired cells prompted us to investigate the ability
of lysosomes to fuse with autophagosomes. In cells transfected
with the autophagosome marker LC3GFP-RFP, GFP fluores-
cence is decreased when autophagosomes fuse with lysosomes
because it is more sensitive to pH than RFP, which is maintained
in acidic compartments. In these experimental settings, control
cells showed increased RFP puncta upon induction of auto-
phagy by rapamycin (Figure 4I). In contrast, Tfam-deficient cells
showed a significant reduction in the number of RFP-positive
puncta, indicating impaired autophagosome-lysosome fusion
in the absence of Tfam. Assessment of mitochondrial degrada-
tion by mitophagy upon acute membrane depolarization with
CCCP revealed larger parkin-GFP aggregates in Tfam-deficient
cells than in control cells (Figure S3D), indicating impaired parkin
clearance and mitochondrial degradation.
In accordance with impaired autophagic flux, Tfam-depleted
cells showed increased levels of the lipidated form of LC3
(LC3-II) (Figure S3E). Additionally, flow cytometry, western blot,
and confocal analysis showed a significant accumulation of the
autophagic substrate p62 in Tfam-deficient cells (Figure 4J).
Blocking protein synthesis with cycloheximide revealed slower
p62 turnover in respiration-impaired cells than in wild-types,
suggesting that the accumulation of p62 was caused by
impaired lysosomal degradation and not by increased mRNA
transcription (Figure 4K).
Cells that lack Tfam exhibit lysosomal defects similar to those
seen in LSDs: abnormal lipid trafficking, altered calcium mobili-
zation, and defective autophagosome-lysosome fusion. Overall,
these results reveal a link between a primary mitochondrial
dysfunction and the acquisition of a lysosomal storage disorder.
Tfam Deficiency Exacerbates Inflammatory Responses
We next assessed how these mitochondrial and endolysosomal
alterations caused by Tfam deficiency affect T cell effector func-
tion. Upon T cell activation, Tfam expression increased concom-
itantly with an increase in mtDNA levels (Figures 5A and S4A),
suggesting that mitochondrial adaptation to T cell activation re-
quires an increase in mtDNA levels. T cells from wild-type and
Tfam/ mice were labeled with the proliferation indicator Cell
Violet, stimulated with anti-CD3 and anti-CD28 antibodies, and
evaluated by flow cytometry. Tfam/ T cells showed reduced
proliferation (Figure 5B). Moreover, upon in vitro cell activation,
there was no evidence of higher apoptosis in Tfam/ T cells,
as assessed by flow cytometry analysis of annexin V and
HOECHST58 staining (Figure S4B). CD4+ Tfam/ cells showed
similar levels of the activation markers CD69 and CD25 (Fig-
ure S4C). Stimulated Tfam/ CD4+ T lymphocytes showed
increased numbers of IFN-g- and T-bet-producing cells
compared to wild-type cells (Figure 5C). RT-PCR analysis indi-
cated strikingly elevated mRNA expression of the proinflamma-
tory cytokines IFN-g, IL-6, IL-1a, and IL-1b, and increased IFN-g
and IL-6 secretion were detected in the supernatant of Tfam/
T cells (Figures 5D, S4D, and S4E). In contrast, IL-4 mRNA levels
and cytokine secretion of IL-4 and IL-10 were below-normal in
Tfam/ cells (Figures S4D and S4E). These in vitro data highlight
the requirement on mitochondrial function for the fine regulation
of T cell responses.
To assess the role of mitochondria in the regulation of the in-
flammatory function of T cells in vivo, we first examined a modelr Inc.
Figure 4. Tfam Controls Lysosomal Function
(A) Lysosomal calcium mobilization in T lymphoblasts loaded with Indo-1, treated with bafilomycin-A1 and detected by flow cytometry. The 340/380 nm ratio is
shown. Right, quantification of Indo-1 signal in bafilomycin-A1- or ionomycin-treated cells relative to basal level.
(B) Histograms and quantification of Cathepsin B activity measured by flow cytometry (MagicRed).
(C) Acid sphingomyelinase (ASM) activity in T lymphocytes.
(D) Heatmap represents cell lipidomic signatures of T cells (n = 3). More intense colors indicate larger drops (green) or elevations (red) of the metabolite levels in
Tfam/ samples. DAG, diacylglyceride; TAG, triacylglyceride; ChoE, cholesteryl ester; PE, phosphatidylethanolamine; PC, phosphatidylcholine; PI; phos-
phatidylinositol; Cer, ceramide; SM, sphingomyelin; CMH, monohexosylceramide. Right, volcano plots (log10 [p value] versus log2 [fold change]) for the
comparison of Tfam/ and WT T cells for the indicated metabolites.
(E) Lysosomal calcium in mt-ND6 Complex I (CI) mutant and WT fibroblasts treated as in (A). Ratio of Indo-1 signal upon bafilomycin-A1 treatment relative to the
basal level.
(F) Relative mRNA levels of TFEB and selected target genes assessed by RT-PCR.
(G) ASM activity in WT and mt-ND6 mutant fibroblasts.
(H) Lysosomal calcium in fibroblasts from patients with point mutation in CI subunit mt-ND5 gene (m.13513G>A), point mutation in the mt-tRNAAsn gene
(m.5658T>C) or control samples assessed as in A.
(I) Left, confocal images show Oli-Neu transfected with LC3-GFP-RFP treated or not with rapamycin. Right graph, percentage of GFP/RFP puncta (yellow
vesicles) and RFP puncta (red vesicles) from at least 100 vesicles in two independent experiments.
(J) Analysis of p62 by western blot, flow cytometry, and confocal immunofluorescence in T lymphoblasts. Chart shows densitometry analysis of p62 by western
blot.
(K) Western blot analysis of p62 turnover in cells treated with cycloheximide for the indicated times. ERMs are used as loading control. Data (A–C, E–H, and J) are
means ± SEM, nR 3; *p < 0.05 and **p < 0.01 (Student’s t test). Scale bars, 10 mm.
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Figure 5. Inhibition of OXPHOS Exacerbates Inflammatory Responses In Vitro and In Vivo
(A) Relative mtDNA and Tfam mRNA levels in naive and CD3/CD28 activated CD4 T cells.
(B) Cell proliferation analysis by Cell Violet dilution of CD4 T cells activated with CD3/CD28.
(C and D) CD4 T cells were activated with CD3/CD28 (6 days), and IFN-g and T-bet intracellular levels were measured by flow cytometry (C), IFN-g secretion by
ELISA and relative IFN-g mRNA levels by RT-PCR (D).
(E and F) (E) Weight and (F) disease score were monitored for the indicated times in mice fed with 3% dextran sulfate sodium (DSS) in the drinking water.
(G and H) H&E staining of colon sections (G) and colon length (H) on day 7 after DSS treatment.
(I) IFN-g-producing CD4 T cells in themesenteric lymph nodes. Data aremeans ± SEM, (A, C, andD, nR 3) (E–I, sevenmice in two independent experiments); *p <
0.05 and **p < 0.01, ***p < 0.001 (Student’s t test).
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Figure 6. Mitochondrial Dysfunction Subverts T Cell Differentiation toward Th1 Cell Subsets
(A) Cell Violet dilution and T-bet expression in CD4 T cells cultured under Th1 and Th2 conditions over 3 days. Chart shows percentage of T-bet expressing cells
(n = 3).
(B) Intracellular flow cytometry analysis of IFN-g-producing cells under Th1 and Th2 conditions over 6 days. Graph, quantification of IFN-g-producing cells (n = 6).
(C) Naive CD4 T cells were cultured under Th17 and Treg conditions over 3 days. Dot plots show RORgT-expressing cells and histograms show cell proliferation
assessed by Cell Violet dilution. Chart shows percentage of RORgT-expressing cells (n = 3).
(D) Intracellular flow cytometry analysis of CD4 T cells producing IL-17 and Foxp3. Chart shows percentage of IL-17 and Foxp3-producing cells (n = 6).
(E and F) Polarized CD4 T cells at day 6 were cultured in equal numbers in fresh medium followed by activation with PMA/ionomycin for 16 hr. Cytokines were
measured by ELISA in the supernatants. Data are means ± SEM (nR 3); *p < 0.05, **p < 0.01, and ***p < 0.001 (Student’s t test).of contact hypersensitivity (CHS), which is mainly mediated by
IFN-g. The specificity of the CHS response is generally defined
as the difference between ear swelling responses to a hapten
such as oxazolone in naive and sensitized animals. Upon sensi-
tization to oxazolone, Tfam/ mice showed larger increases in
ear thickness, lymph node cellularity, and IFN-g-producing
CD4+ T lymphocytes (Figure S4F). In addition, we performed a
model of DSS-induced colitis, which is driven by Th1 and Th17
cells and suppressed by Treg cells. Wild-type mice and Tfam/
mice were fed with DSS to induce gut damage and trigger dis-
ease. Tfam/ mice showed increased disease severity, as re-
flected by higher weight loss over time, increased disease score,
and shorter colon length thanWTmice (Figures 5E–5H, S4G, and
S4H). Remarkably, Tfam deficiency increased the frequency of
IFN-g- and T-bet-expressing CD4+ T cells in the mesenteric
lymph nodes upon DSS treatment (Figures 5I and S4I). These re-
sults indicate that respiration-impaired T cells develop a stronger
inflammatory response in vitro and in vivo and support a critical
role for mitochondria in the regulation of T cell effector functions
during immune responses.Cell MeMitochondrial Dysfunction Deviates T Cell
Differentiation toward Proinflammatory Th1 Subsets
To provide further insights into how mitochondrial function
controls T cell differentiation, we assessed the ability of Tfam-
deficient T cells to differentiate into effector T cell subsets. The
balance among different functional effector T cell subsets deter-
mines the outcome of the immune response and is essential to
prevent undesired inflammation and autoimmune diseases.
Naive CD4+ T cells were labeled with Cell Violet; differentiated
in vitro with different cytokines and neutralizing antibodies to
Th1, Th2, Th17, and regulatory (Treg) T cell subsets; and as-
sessed for proliferation and expression of transcription factors
and cytokines. Tfam deficiency greatly impaired proliferation in
all the skewing conditions (Figures 6A and 6C). Tfam-depleted
cells showed higher expression of the Th1-specific transcription
T-bet, higher numbers of IFN-g-producing cells, and higher
levels of IFN-g secretion (Figures 6A, 6B, and 6E). In all polariza-
tion conditions, Tfam/CD4+ T cells secreted less IL-4 thanWT
cells (Figure 6E), demonstrating a Th1/Th2 imbalance toward the
Th1 response in the absence of Tfam.tabolism 22, 485–498, September 1, 2015 ª2015 Elsevier Inc. 493
When polarized toward Th17 T cell subsets, no substantial dif-
ferences were found in the number of RORgt-expressing cells
between Tfam/ and WT cells (Figure 6C). However, impaired
mitochondrial function in Tfam/ CD4+ T cells significantly
reduced the levels of IL-17-producing cells and impaired IL-17
and IL-10 secretion (Figures 6D and 6F), while increasing IFN-g
secretion (Figure 6E). In Treg conditions, no significant differ-
ences were found in the number of Foxp3-expressing cells,
but Tfam/ CD4+ T cells secreted reduced amounts of anti-in-
flammatory cytokine IL-10 (Figures 6D and 6F). Thus, Tfam defi-
ciency favored the appearance of Th17 cells which coexpress
RORgt and T-bet, and produce high levels of IFN-g but reduced
amounts of IL-10, and which have been proposed to be patho-
genic Th17 cells involved in autoimmune diseases in mice (Pe-
ters et al., 2011). Collectively, these results reveal a role for mito-
chondrial function in the regulation of T cell differentiation and
indicate that mitochondrial dysfunction is associated with a
deregulation of T cell differentiation toward proinflammatory
Th1 cell subsets.
Increasing Intracellular NAD+ Content Boosts
Lysosomal Function and Dampens Th1 Responses in
Respiration-Impaired Cells
We then investigated whether lysosomal dysfunction caused by
mitochondrial respiration deficiency is involved in the increased
inflammatory responses observed in Tfam-deficient cells. Naive
CD4+ T cells activated in the presence of the lysosomal inhibitor
leupeptin or SM showed increased levels of IFN-g mRNA (Fig-
ure S5A), suggesting that the lysosomal dysfunction might
contribute to the increased proinflammatory profile of Tfam/
CD4+ T cells. To ascertain the involvement of lysosome function
in the regulation of T cell responses, we studied T cell activation
and differentiation in mice lacking ASM, which mimics the LSD
Niemann-Pick disease type A (NPA) and, similarly to Tfam/,
shows SM accumulation, lysosomal disorder, and autophagy
impairment (Gabande´-Rodrı´guez et al., 2014). Naive CD4+
T cells from ASM/ mice activated in nonskewing conditions
showed a higher frequency of IFN-g-producing cells and higher
levels of IFN-g secretion than WT (Figure 7A). Similarly to respi-
ration-impaired Tfam/ cells, ASM/ cells showed higher fre-
quency of IFN-g-producing cells in Th1 conditions, and reduced
frequency of IL-17-producing cells in Th17 skewing conditions
(Figure 7B). T cells from ASM/ mice did not show appreciable
mitochondrial alterations in terms of mitochondrial mass, mROS,
ATP production, and OCR (Figures S5B–S5D). Collectively,
these results show that lysosome dysfunction is sufficient to
deregulate T cell differentiation toward proinflammatory Th1
subsets.
Increasing intracellular levels of NAD+ has been proposed
to be a therapeutical strategy to restore mitochondrial function
in respiratory-chain deficiencies (Cerutti et al., 2014; Gomes
et al., 2013; Karamanlidis et al., 2013). To assess whether mod-
ulation of the cellular NAD+/NADH ratio may be involved in the
regulation of lysosomal function, we treated Tfam-deficient
T cells with the nicotinamide precursor NAM to reestablish
NAD+/NADH balance, and assessed parameters of lysosome
function. Addition of NAM increased ASM activity, reduced
p62 accumulation, and downregulated TFEB target genes in
Tfam-deficient cells (Figures 7C–7E), suggesting thatmodulation494 Cell Metabolism 22, 485–498, September 1, 2015 ª2015 Elsevieof mitochondrial NAD+/NADH levels impacts lysosome function.
Finally, to determine whether restoring NAD+/NADH levels
would limit the increased proinflammatory profile in respiration-
impaired Tfam/ T cells, naive CD4+ T cells were activated
in the presence of NAM for 72 hr and their cytokine profile
assessed. NAM treatment reduced the frequency of IFN-g-pro-
ducing Tfam/ T cells (Figure S5E). Additionally, under Th1
polarization conditions, naive Tfam/ CD4+ T cells cultured in
the presence of NAM showed a reduced percentage of IFN-g-
producing cells (Figure 7F), indicating that improved lysosomal
function reduces the exacerbated inflammatory response of
mitochondrial respiration-impaired cells.
DISCUSSION
Our findings reveal a mechanism through which mitochondrial
respiration preserves cellular homeostasis by regulating the
function of the endolysosomal compartment during essential
biological processes, illustrated here in the regulation of T cell
function. We show that lack of Tfam in T cells decreases cellular
mtDNA content, alters mitochondrial metabolism, and is associ-
ated with impaired endolysosomal function, abnormal accumu-
lation of SMs, and increased proinflammatory T cell responses
(Figure 7G).
We provide here evidence for primary mitochondrial dysfunc-
tion leading to altered lysosomal function and sphingolipidosis.
Cells lacking Tfam exhibit abnormal lipid trafficking, altered lyso-
somal Ca2+ mobilization, and autophagosome-lysosome fusion,
defects similar to those seen in LSDs. In Niemann-Pick (NP) type
A and B diseases (NPA and NPB), SM accumulates in lysosomes
due to insufficient activity of ASM. SM accumulation has been
found to inhibit the main calcium channel in the lysosome, im-
pairing endolysosomal trafficking, protein degradation, and
macroautophagy (Gabande´-Rodrı´guez et al., 2014; Shen et al.,
2012). Our findings demonstrate that mitochondrial dysfunction
results in autophagosome-lysosome fusion defects and reduced
mitochondrial clearance by mitophagy, which are commonly
observed in almost all sphingolipidoses (Lieberman et al.,
2012). A predominant nuclear localization of TFEB has been de-
tected in cells frommouse models of LSD (Sardiello et al., 2009).
Mitochondrial respiration deficiency increases TFEB activation,
suggesting that the TFEB pathway is activated as a cellular
response to lysosomal stress after intralysosomal storage of
nondegraded molecules.
Lysosomal calcium level is impaired not only by Tfam deletion,
which triggers a general lowering of the levels of mtDNA, but also
in cells from patients with point mutations in mitochondrial respi-
ratory complex I (CI). Mitochondrial CI is essential for mainte-
nance of the NAD+/NADH ratio through NADH dehydrogenase
activity, and an imbalanced NAD+/NADH ratio in cancer cells
with mutations in CI subunits is associated with impaired auto-
phagy and p62 degradation (Santidrian et al., 2013). Inhibition
of CI activity with rotenone in a mouse model of Parkinson’s dis-
ease impairs autophagic flux and promotes p62 and a-synuclein
accumulation (Wu et al., 2015). Our data demonstrate that NAD+
precursors restore ASM activity, prevent p62 accumulation, and
downregulate TFEB target genes in Tfam-deficient cells, thus
supporting a role of mitochondrial CI and NAD+/NADH ratio in
the regulation of lysosomal function. These data support ther Inc.
Figure 7. Increasing NAD+ Levels Improves Lysosome Function and Reduces Inflammatory Responses in Tfam-Deficient Cells
(A) Dot plots show intracellular IFN-g levels by flow cytometry in CD4 T cells activated with CD3/CD28 (6 days). Graphs show percentage of IFN-g-producing cells
and IFN-g levels in the supernatant by ELISA.
(B) CD4 T lymphocytes cultured under Th0, Th1, and Th17 condition for 6 days. Flow cytometry analysis of the frequency of CD4 T cells producing IFN-g and
IL-17.
(C and D) (C) ASM activity and (D) flow cytometry analysis of p62 levels in T-lymphoblasts treated with NAM (10mM) for 2 days.
(E) Relative mRNA levels of TFEB target genes in T cells incubated or not with NAM.
(F) CD4 T cells cultured toward Th1 in the presence or absence of NAM for 3 days. Flow cytometry analysis of the frequency of CD4 T cells producing IFN-g.
(G) Diagram representing the proposed mechanism. Data are means ± SEM (nR 3); *p < 0.05, **p < 0.01 and ***p < 0.001 (Student’s t test).notion that lysosomes adapt their biogenesis and function to the
metabolic state of the cell by sensing intracellular NAD+/NADH
levels. Further research is necessary to understand how NAD
precursors reestablish ASM activity and control lysosomal func-
tion, andwhether it relies on transcriptional regulation by sirtuins,
NAD-dependent deacetylases.
Recent studies support the contribution of lysosomal homeo-
stasis to the regulation of T cell function during adaptive immune
responses (Valdor et al., 2014). The lysosomal dysfunction and
elevated SM levels in Tfam-deficient cells might be responsible
for the acquisition of a proinflammatory profile, since similar
cytokine profile was found in ASM/ T cells, which presentedCell Melysosomal dysfunction without altered mitochondrial respiration.
Together, our results indicate that loss of lysosomal homeostasis
by a primary mitochondrial dysfunction triggers proinflammatory
T cell responses. Lysosomal function could regulate immune
response by modulating cellular metabolism. By degrading key
glycolytic enzymes, lysosome function regulates glycolysis and
the production of effector cytokines, including IFN-g and IL-1b
(Lu et al., 2014).
Our results shed light on how metabolic reprogramming to-
ward anaerobic glycolysis and the alterations to the endolysoso-
mal compartment affect T cell differentiation to effector lineages.
It has been reported that Th1, Th2, and Th17 lineages display atabolism 22, 485–498, September 1, 2015 ª2015 Elsevier Inc. 495
strong bias toward glycolysis over mitochondrial metabolism,
whereas Treg cells have a mixed metabolism involving glycol-
ysis, lipid oxidation, andOXPHOS (Gerriets et al., 2015;Michalek
et al., 2011). Metabolic reprogramming toward glycolysis in
Tfam/ T cells could contribute to their proinflammatory pheno-
type, since glycolysis enhances IFN-g expression by preventing
GAPDH from its binding to the 30UTR of IFN-g mRNA (Chang
et al., 2013). Glycolysis is important in driving Th17 differentiation
through Hif-1a (Pearce et al., 2013). In addition, impaired mito-
chondrial respiration induces succinate accumulation, which im-
pairs prolyl hydroxylase activity, stabilizing Hif-1a and enhancing
IL-1b production (Tannahill et al., 2013). Tfam depletion favors
the differentiation of Th1 subsets, dampens Th2 differentiation,
and inhibits Th17 T cell subsets. Interestingly, in Th17-skewing
conditions, Tfam-deficient cells showed reduced IL-17 and IL-
10 but increased IFN-g secretion, which suggests that cues
frommitochondria can modulate the differentiation toward path-
ogenic Th17 cells.
Defects in mitochondrial homeostasis are closely linked to the
development of human pathologies such as cancer, inflamma-
tion, neurodegenerative diseases, andmetabolic disorders (Tay-
lor and Turnbull, 2005), and are also a recurrent hallmark of
aging (Lo´pez-Otı´n et al., 2013). In summary, our findings on the
role of mitochondrial respiration as a regulator of endolysosomal
function could therefore provide potential insights into the in-
volvement of mitochondria in human diseases and aging. These
findings provide evidence for a functional link between mito-
chondrial respiration and the endolysosomal system, with impli-
cations for treating mitochondrial-related diseases.
EXPERIMENTAL PROCEDURES
Mice, Antibodies, and Reagents
All animal experiments were performed in the specific pathogen-free facilities
at CNIC in accordance with European Union recommendations and in-
stitutional guidelines. Tfamfl/fl mice were kindly provided by N.G. Larsson
(Larsson et al., 1998), and CD4Cre+/wt mice were purchased from the Jackson
Laboratory. Double heterozygotes (Tfam+/fl, CD4Cre+/wt) were obtained and
backcrossed to the Tfamfl/fl strain to generate tissue-specific knockouts
(CD4Cre+/wt Tfamfl/fl). ASM/ mice were kindly donated by E.H. Schuchman
(Mount Sinai School of Medicine, New York). Sources of chemical and biolog-
ical reagents detailed in Supplemental Experimental Procedures.
Cells, Plasmids, and Cell Transfection
Naive CD4+ T cells were obtained by negative selection using the auto-MACS
Pro Separator (Miltenyi Biotec). Where stated, cells were activated by stimula-
tion on plates coated with anti-CD3 (5 mg ml1) and soluble anti-CD28 (2 mg
ml1). To obtain differentiated T lymphoblasts, naive CD4+ cells were cultured
for 36–48 hr with 2 mgml1 concanavalin A, and 50Uml1 IL-2 was added every
2 days. Balb/cJ and mt-ND6 (FG23-1) mutant cell line were described (Acı´n-
Pe´rez et al., 2014). Human fibroblasts from a control, a patient with a point
mutation in mt-ND5 gene (m.13513G>A), and a patient with a point mutation
inmt-tRNAAsn gene (m.5658T>C) were obtained from skin biopsies for research
purposes after written consent in accordance with the Helsinki declaration. The
human Jurkat T and the oligodendroglia Oli-Neu cell lines were silenced by len-
tiviral infection as detailed in Supplemental Experimental Procedures.
T Cell Differentiation, Proliferation, and Intracellular Staining
Naive CD4+ CD25 T lymphocytes were obtained from cell suspensions pre-
pared from spleen and peripheral lymph nodes (LN) of Tfamfl/fl (wild-type) and
CD4+Cre+/wt Tfamfl/fl (Tfam/) mice. Pooled spleen and LN cells were incu-
bated with biotinylated antibodies to IgM, B220, CD19, CD8, Gr-1, CD44,
CD25, MHC-II, F4/8, CD11c, CD11b, and DX5 (BD Pharmingen) followed by496 Cell Metabolism 22, 485–498, September 1, 2015 ª2015 Elsevienegative selection using the auto-MACS Pro Separator (Miltenyi Biotec). For
in vitro activation, naive CD4+ T cells were incubated in the presence of 5 mg
ml1 plastic-bound purified anti-CD3, 2 mg ml1 soluble anti-CD28, and
100 U ml1 human IL-2. For Th0 conditions, anti-IFN-g (4 mg ml1) and IL-4
(4 mg ml1) were added. For Th1 conditions, culture was supplemented with
IL-12 (10 ng ml1) and anti-IL-4 (4 mg ml1). For Th2 conditions, IL-4 (10 ng
ml1) and anti-IFN-g (10 mg ml1) were added. For Th17 conditions, anti-IL-2
(10 mg ml1), anti-IL-4 (10 mg ml1), anti-IFN-g (10 mg ml1), TGF-b (5 ng
ml1), IL-23 (20 ng ml1), and IL-6 (20 ng ml1) were included in cultures. For
Treg cell differentiation, TGF-b (10 ngml1) was added. For proliferation assays,
cells were labeled with Cell Violet (1 mM). For intracellular staining of transcrip-
tion factors, cells were differentiated for 3 days, fixed, permeabilized, and
stainedwith anti-RORgT and anti-T-bet (BDBiosciences). For intracellular cyto-
kine staining, cells were restimulated for 4 hr with PMA and ionomycin in the
presence of brefeldin, fixed, permeabilized, and stained with anti-CD4, anti-
IFN-g, anti-IL-17, and anti-Foxp3. Datawere acquired on a FACSCanto flowcy-
tometer (BD Biosciences) and analyzed with FLOWJO software (Tree Star).
Quantitative Real-Time PCR and mtDNA Analysis
Total RNA was extracted from cells using the RNeasy kit (QIAGEN), and cDNA
was synthesized with the High-Capacity cDNA Reverse Transcription Kit
(Applied Biosystems). Triplicate reactions were run on a 7500 Fast Real-
Time PCR System (Applied Biosystems) using SYBR Green PCR reagents
(Applied Biosystems). Data were normalized to the expression of b-actin and
b-2-microglobulin and analyzed using Biogazelle QBasePlus software (Bio-
gazelle). For analysis of mtDNA levels, total DNA was extracted with the
DNeasy kit (QIAGEN), amplified using primers specific for cytochrome c oxi-
dase subunit 1 (mtCO1) and NADH dehydrogenase 1 (mtND1), and normalized
to succinate dehydrogenase (SDH) nuclear gene.
Survival Assays
T lymphoblasts were cultured in RPMI 1640 containing glucose or in RPMI
1640 deprived of glucose (Life Technologies) supplemented with 5 mM galac-
tose and dialyzed FBS. Viable cells were analyzed by HOECHST58 exclusion
by flow cytometry.
Mitochondrial Content and ROS
Mitochondrial mass and mitochondrial-derived ROS levels were measured by
flow cytometry after labeling cells with Mitotracker green (50 nM) or MitoSOX
(2.5 mM).
Extracellular Flux Analysis and Metabolic Assays
OCRs and extracellular acidification rates (ECAR) were measured in a XF-96
Extracellular Flux Analyzers (Seahorse Bioscience) in cells suspended in XF
medium (nonbuffered RPMI 1640 containing either 25 mM glucose or 1 mM
palmitate, 2 mM L-glutamine, and 1 mM sodium pyruvate). Three measure-
ments were obtained under basal conditions and upon addition of oligomycin
(1 mM), fluoro-carbonyl cyanide phenylhydrazone (FCCP; 1.5 mM), and rote-
none (100 nM) + antimycin A (1 mM).
Lysosomal Calcium Mobilization, Content, pH, and Activities
Lysosomal calcium was measured in cells loaded with INDO-1 (2 mM), and
fluorescence intensity ratio at 340/380 nmwas detected by flow cytometry. Af-
ter basal recording, cells were treated with bafilomycin-A1 (1 mM, Sigma) to
promote lysosomal calcium release for the indicated times. Lysosomal content
was determined by flow cytometry after incubation with Lysotracker. Lyso-
somal pH was determined by dual-excitation and dual-emission measure-
ments by flow cytometry with the ratiometric lysosomal pH probe LysoSensor
Yellow/Blue DND-160 (Life Technologies, 2 mM). For analysis of Cathepsin B
activity, cells were incubated 30 min with Magic Red (Immunochemistry Tech-
nologies) and measured by flow cytometry. Acid phosphatase activity (Sigma)
and ASM activity (AAT Bioquest) were performed in total cell lysates following
manufacturer’s instructions.
Blue Native Gel Electrophoresis, Mitochondrial Complex Activities,
and Mitochondrial Membrane Potential Assays
For supercomplex assembly, T lymphocytes were lysed in the presence of
digitonin and proteins separated on 5%–13% gradient blue native gelsr Inc.
(Acı´n-Pe´rez et al., 2014). Total ATP and mitochondrial-derived ATP synthesis
in T cell lysates was measured by kinetic luminescence assay, and activities
of individual complexes were measured spectrophotometrically as described
(Acı´n-Pe´rez et al., 2014). For mitochondrial potential assays, cells were labeled
with tetramethylrhodaminemethyl ester (TMRM, 100 nM) and analyzed by flow
cytometry upon incubation with oligomycin (200 nM) for the indicated times.
Confocal Microscopy Analysis of Autophagy and Mitophagy
Oli-Neu cells were transfected using Lipofectamine (Invitrogen) with LC3-GFP-
RFP, and treated or not with Rapamycin (200 nM, Sigma) for 3 hr. For mitoph-
agy assays, Oli-Neu cells transfected with Parkin-GFPwere treated or not with
CCCP (2 mM) for 3 hr. Cells were examined with a Leica SP5 confocal micro-
scope (Leica) and analyzed with ImageJ software (NIH).
DSS-Induced Colitis Model
Colitis was induced by daily administration of 3% Dextran Sodium Sulfate
(DSS, Mw 30.000–40.000) for 7 days in drinking water. The clinical parameters
used to score the disease were weight loss, loose stools/diarrhea, and pres-
ence of occult/gross bleeding. At the end of treatment, colons were processed
for histological analysis, and mesenteric lymph nodes were processed to
study cytokine production of immune cells by flow cytometry.
Statistical Analyses
All values were expressed as the mean ± SEM. For in vitro experiments, statis-
tical analyses were calculated with Student’s t test; for in vivo experiments, dif-
ferences between groups were calculated using the Mann-Whitney U test for
unpaired data (GraphPad Prism). Differences were considered significant
when *p% 0.05, **p% 0.01, ***p% 0.001.
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